The officials made the prediction at a press conference held at the council to disclose the research results of the Institute of Nuclear Energy Research (INER) on a newly developed micro-PET/CT system for animal imaging.

The system can serve the dual purpose of providing tumor imaging to help doctors’ diagnosis and increasing precision in the dosage of medicine.

Jan Mei-ling, associate researcher at INER, pointed out that in vivo molecular imaging techniques have seen rapid development over the past decade, and that the non intrusive nuclear imaging method provides three-dimensional information on animal molecules.

She added that the method is a technology acknowledged by the Food and Drug Administration (FDA) of the United States as useful in shortening the time period for developing new medicines.

She also said that Current Medical Imaging Reviews, a renowned international journal, has published an article on the INER developed imaging system.

INER will apply for FDA certification for the new imaging system and will not rule out the possibility of tapping the world market even before obtaining the FDA certification, she added.

Subscribe to The China Post and save.  Click hereSharePrintEmail

Write a Comment

Enter your comments - 800 characters max

Receive China Post promos

Respond to this email